MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma
Among transplant-eligible patients with NDMM, the prognostic stratification value of MASS-4 was better than that of MASS-3, particularly distinguishing high-risk patients with poor prognosis. Compared with single ASCT, tandem ASCT may overcome the poor prognosis of high-risk MASS patients.
Authors
- Lifen Kuang
- Meilan Chen
- Beihui Huang (ORCID: https://orcid.org/0000-0003-2804-4913)
- Juan Li (ORCID: https://orcid.org/0000-0002-7489-4778)
- Jingli Gu
- Junru Liu (ORCID: https://orcid.org/0000-0001-6462-3547)
- Fan Yang (ORCID: https://orcid.org/0009-0001-0454-2291)
Institutions
- Sun Yat-sen University (CN)
- First People's Hospital of Foshan (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1080/07853890.2025.2519671
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China